TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Eclipse Biofarm AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
16,061
|
16,884
|
15,460 |
| Financial expenses |
198
|
63
|
1 |
| Earnings before taxes |
139
|
1,000
|
779 |
| EBITDA |
602
|
1,301
|
1,127 |
| Total assets |
9,806
|
11,650
|
7,116 |
| Current assets |
7,388
|
9,708
|
5,675 |
| Current liabilities |
5,818
|
7,800
|
4,094 |
| Equity capital |
3,742
|
3,623
|
2,867 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
6
|
8
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
38.2%
|
31.1%
|
40.3% |
| Turnover per employee |
2,677
|
2,110
|
3,092 |
| Profit as a percentage of turnover |
0.9%
|
5.9%
|
5.0% |
| Return on assets (ROA) |
3.4%
|
9.1%
|
11.0% |
| Current ratio |
127.0%
|
124.5%
|
138.6% |
| Return on equity (ROE) |
3.7%
|
27.6%
|
27.2% |
| Change turnover |
-823
|
1,424
|
305 |
| Change turnover % |
-5%
|
9%
|
2% |
| Chg. No. of employees |
-2
|
3
|
0 |
| Chg. No. of employees % |
-25%
|
60%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.